Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2025-12-24 @ 5:18 PM
NCT ID:
NCT00653250
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Presumed histological or cytological diagnosis of non-small cell lung cancer
* Diagnosis to be confirmed upon study entry to collect biopsy material for correlative studies
* Stage I-IIIA disease
PATIENT CHARACTERISTICS:
* ECOG performance status of 0-2
* Serum creatinine ≤ 1.5 mg/dL
* Granulocytes ≥ 1,500/mm\^3
* Platelets ≥ 100,000/mm\^3
* AST ≤ 3 times normal
* Bilirubin ≤ 1.5 mg/dL
* Not pregnant or nursing
* Fertile patients must use effective contraception
* No active unresolved infection
PRIOR CONCURRENT THERAPY:
* At least 7 days since prior and no concurrent non-steroidal anti-inflammatory agents or other cyclo-oxygenase-2 inhibitors
* At least 7 days since prior parenteral antibiotics
* No prior systemic chemotherapy or radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00653250
Study Brief:
Protocol Section:
NCT00653250